A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Now, healthcare specialists at ZAVA have put together a step-by-step guide on what to expect if you are taking the jabs. Dr ...

Novo Nordisk markets its semaglutide drugs as Ozempic pre-filled pens and Rybelsus oral tablets for type II diabetes (T2D) and as Wegovy injection for weight management.

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today.